Table 3.
Characteristics of women with prevalent HIV infection using ART at enrollment, by contraceptive method selected.
| COCs (N=24) | DMPA (N=17) | Nonhormonala (N=36) | |
|---|---|---|---|
| Enrollment CD4 count (cells/mm3): median, IQR | 305, 213–420 | 430, 319–493 | 351, 252–449 |
| Viral suppression at enrollment (HIV RNA ≤150 copies per milliliter) | 23 (95.8) | 12 (70.6) | 29 (80.6) |
| HAART regimen | 22 (91.7) | 15 (88.2) | 32 (88.9) |
| Months on ARTb | |||
| 3–6 months | 8 (33.3) | 11 (64.7) | 7 (19.4) |
| 7–12 months | 6 (25.0) | 3 (17.7) | 10 (27.8) |
| >12 months | 10 (41.7) | 3 (17.7) | 19 (52.8) |
| Time since HIV diagnosis | |||
| <1 year | 3 (12.5) | 1 (5.9) | 2 (5.6) |
| 1–2 years | 4 (16.7) | 1 (5.9) | 7 (19.4) |
| >2 years | 17 (70.8) | 15 (88.2) | 27 (75.0) |
| Age (years) | |||
| 16–24 | 9 (37.5) | 5 (29.4) | 3 (8.3) |
| 25–29 | 9 (37.5) | 7 (41.2) | 18 (50.0) |
| 30–45 | 6 (25.0) | 5 (29.4) | 15 (41.7) |
| Married or nonmarital union | 20 (83.3) | 14 (82.4) | 30 (83.3) |
| Previous abortion | |||
| Yes | 13 (54.2) | 12 (70.6) | 27 (75.0) |
| No | 7 (29.2) | 5 (29.4) | 6 (16.7) |
| Never pregnant | 4 (16.7) | 0 (0.0) | 3 (8.3) |
| Previous live births | |||
| 0 | 10 (41.7) | 1 (5.9) | 9 (25.0) |
| 1 | 12 (50.0) | 11 (64.7) | 21 (58.3) |
| >2 | 2 (8.3) | 5 (29.4) | 6 (16.7) |
| Postpartum (≤6 weeks) | 5 (20.8) | 8 (47.1) | 8 (22.2) |
| Prior hormonal contraception use | 11 (45.8) | 3 (17.7) | 8 (22.2) |
| Frequency of condom usec | |||
| Always | 6 (25.0) | 6 (35.3) | 22 (61.1) |
| Rarely/sometimes/almost always | 16 (66.7) | 7 (41.2) | 14 (38.9) |
| Never | 2 (8.3) | 4 (23.5) | 0 (0.0) |
| Multiple partners in previous year | 3 (12.5) | 0 (0.0) | 3 (8.3) |
| Positive STD test at enrollmentd | 2 (8.3) | 1 (5.9) | 0 (0.0) |
| Use of intravenous drugs in the past 3 monthsc | 1 (4.2) | 2 (11.8) | 0 (0.0) |
Data are shown as number (percentage) unless otherwise indicated.
Statistical tests of significant differences were based on Kruskal–Wallis test, chi-squared test or Fisher’s Exact Test, as appropriate. ART, antiretroviral therapy; IQR, interquartile range.
a
Includes participants choosing the copper IUD (n=9) and condoms (n=27).
b
p<.05, chi-squared test.
c
p<.05, Fisher’s Exact Test.
d
Chlamydia or gonorrhea.